Grove Collaborative Holdings, Inc. quarterly report, Q1 FY2021

Filing summary

Entity and period: The supplied filing is for Virgin Group Acquisition Corp. II, not Grove Collaborative Holdings, Inc. It is a SPAC’s Form 10-Q for the period from inception on January 13, 2021 through March 31, 2021; results therefore have no prior comparable operating period.

Business context and financial results

The company was formed to pursue a business combination, had selected no target and had not begun operations by March 31. It completed its IPO on March 25, 2021. It reported no operating revenue.

  • Results: Operating loss was $27,356 and net loss was $732,339. Net loss included $497,634 of offering costs allocated to warrants, warrant fair-value expense, and $1,444 of trust-account interest income. The filing’s statement of operations reports a $208,793 warrant fair-value loss, while Note 9 reports a $188,774 change; the filing text does not provide a clear reconciliation.
  • Cash flow: Operating cash use was $5,000; investing cash use was $350.0 million, primarily funds placed in trust; financing provided $351.4 million. Ending operating cash was $1.42 million.
  • Balance sheet and liquidity: Total assets were $352.67 million, including $350.00 million in trust. Current liabilities were $1.27 million; total liabilities were $31.50 million, including $17.99 million of warrant liabilities and $12.25 million of deferred underwriting fees. Working capital was approximately $1.40 million. Shareholders’ equity was $5.00 million; no long-term debt was reported.
  • Margins: Not meaningful for a pre-operating SPAC; no revenue was reported.

Material changes, outlook and risks

  • Warrant accounting restatement: After an April 12, 2021 SEC staff statement, the company revised its accounting to classify public and private warrants as fair-value liabilities rather than equity. The March 25 balance sheet was revised to recognize approximately $17.8 million of warrant liabilities, with a corresponding reduction in redeemable shares; total shareholders’ equity was unchanged. Subsequent fair-value changes will affect earnings and may cause period-to-period volatility.
  • Subsequent IPO over-allotment: On April 13, underwriters exercised the option in full, adding 5.25 million units and $52.5 million of gross proceeds; the sponsor purchased 700,000 additional warrants for $1.05 million. The filing reports approximately $402.5 million in trust after the offering and $166,264 outside trust as of that date. Deferred underwriting fees increased to $14.09 million.
  • Outlook: Management expected available working capital and borrowing capacity to cover needs through the earlier of a business combination or one year from the filing. The company expected ongoing search and transaction costs, and did not assure that it would complete a combination. Public shares were subject to redemption; warrants could expire worthless if no combination is completed within 24 months of the IPO.
  • Controls and risks: Management concluded disclosure controls were ineffective because of a material weakness in accounting for warrants. It described planned process enhancements but gave no assurance remediation would succeed. Management also noted that COVID-19 could affect the company’s financial position or target search, though the specific impact was not determinable. No legal proceedings were reported.

Investor verification priorities

  • Verify the issuer: this filing identifies Virgin Group Acquisition Corp. II, not Grove Collaborative Holdings, Inc.
  • Reconcile the warrant fair-value change: the statement of operations and Note 9 give different amounts ($208,793 and $188,774).
  • Review the warrant-liability restatement, valuation assumptions, and progress in remediating the material weakness.
  • Confirm the post-quarter trust balance, outside-trust cash, deferred underwriting fees, and the SPAC’s business-combination deadline and redemption terms.